FDA Inspection 1063598 — Penn Pharmaceutical Services Limited

Penn Pharmaceutical Services Limited — FEI 1000370240

The FDA completed an inspection of Penn Pharmaceutical Services Limited on January 26, 2017 in Tredegar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tredegar (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)